Managing Phosphorus in Acute Kidney Injury

Phosphorus Management Guidelines

The American Journal of Kidney Diseases recommends maintaining serum phosphorus between 3.5-5.5 mg/dL to reduce cardiovascular morbidity and mortality in patients with Stage 5 kidney failure requiring dialysis 1, 2, 3, 4
The National Kidney Foundation suggests restricting dietary phosphorus to 800-1,000 mg/day when serum phosphorus exceeds 5.5 mg/dL in patients with acute kidney injury progressing to Stage 5 or dialysis-dependent 3, 4, 5
The American Journal of Kidney Diseases advises initiating phosphate binders if dietary restriction fails to maintain phosphorus ≤5.5 mg/dL in patients with acute kidney injury progressing to Stage 5 or dialysis-dependent 3, 4
The Annals of Internal Medicine warns against using phosphate binders in AKI patients with normal phosphorus levels, as this can precipitate dangerous hypophosphatemia, particularly during RRT 6, 4

The American Journal of Kidney Diseases recommends monitoring phosphorus monthly after treatment initiation in patients with acute kidney injury progressing to Stage 5 or dialysis-dependent 3, 4, 5
The National Kidney Foundation suggests limiting elemental calcium from binders to ≤1,500 mg/day, total calcium intake ≤2,000 mg/day in patients with acute kidney injury progressing to Stage 5 or dialysis-dependent 3, 4
The American Journal of Kidney Diseases advises switching to non-calcium binders (sevelamer, lanthanum) if hypercalcemia develops or PTH <150 pg/mL in patients with acute kidney injury progressing to Stage 5 or dialysis-dependent 3, 4